9955.Hk
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.
Business. The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services, primarily generating revenue through the sale and distribution of medical products.
The company's capital structure shows a debt-to-equity ratio of 0.53, indicating a moderate reliance on debt financing. However, its liquidity position is constrained, with a current ratio of 1.03, suggesting limited short-term liquidity to cover immediate obligations. The company's cash and equivalents amount to 267.6 million CNY, but this is offset by long-term debt of 288.6 million CNY, resulting in a net cash position that is negative.
Profitability metrics are weak, with a return on equity of -1.68 and a return on assets of -0.55, both significantly below industry norms. The company reported a net loss of 924.2 million CNY and an operating loss of 934.2 million CNY, indicating a challenging operating environment and potential inefficiencies in cost management.
The company's revenue is not segmented by product or geographic region in the available data, making it difficult to assess the concentration of risk or growth potential in specific areas. However, the lack of detailed segment reporting suggests a potentially concentrated business model, which could increase vulnerability to market or regulatory shifts.
Looking ahead, the company is expected to face continued financial pressure, with no clear indication of a turnaround in the near term. The operating and net losses suggest a need for significant operational or strategic changes to restore profitability. The absence of positive revenue growth or margin improvement in the data implies a challenging outlook for the current fiscal year.
The company's risk profile is elevated, with a medium liquidity risk and a negative net cash position. While dilution risk is currently assessed as low, the company's financial performance and capital structure suggest a potential need for additional financing in the future, which could lead to share dilution. The adjustments applied in the valuation process reflect the company's weak financial position and the associated risks.
Recent financial filings and disclosures indicate a deteriorating financial position, with significant losses and a negative return on equity. The company has not disclosed any major strategic initiatives or operational improvements in the latest filings, which may raise concerns about its ability to address its financial challenges. The lack of positive developments in the recent transcripts and filings suggests a need for further monitoring of the company's strategic direction and financial health.
- The company is operating at a significant loss, with a net income of -924.2 million CNY and an operating income of -934.2 million CNY.
- The company's liquidity position is weak, with a current ratio of 1.03 and a negative net cash position after accounting for long-term debt.
- Profitability metrics are poor, with a return on equity of -1.68 and a return on assets of -0.55, both well below industry norms.
- The company's financial performance suggests a need for significant operational or strategic changes to restore profitability and improve liquidity.
- The company's risk profile is elevated, with medium liquidity risk and a potential need for additional financing in the future.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Return On Assetsnet_income / total_assets
- 9955.HK Market data — financials · 2026-05-27